---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-23-000007"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2023-01-30T23:59:59+00:00"
generated_at: "2026-06-20T06:50:25.914307+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare Q4 revenue $4.9B, adj EPS $1.31; FY23 adj EPS guidance $3.60-$3.75

## Summary
- Q4 revenue $4.9B (+8% reported, +13% organic); net income $554M, EPS $1.21, adjusted EPS $1.31.
- FY22 revenue $18.3B (+4% reported, +7% organic); net income $1.9B, EPS $4.18, adjusted EPS $4.63.
- FY23 guidance: organic revenue growth 5-7%, adj EBIT margin 15.0-15.5%, adj EPS $3.60-$3.75, FCF conversion 85%+.
- Cash from operations $2.1B, free cash flow $1.8B for FY22; cash conversion 111%.
- Announced agreement to acquire IMACTIS to strengthen interventional guidance capabilities.

## SEC filing metadata
- accession: 0001932393-23-000007
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2023-01-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239323000007/0001932393-23-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239323000007/gehc-20230130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-23-000007
- JSON: https://secwatch.observer/filing/0001932393-23-000007.json
- Plain text: https://secwatch.observer/filing/0001932393-23-000007.txt

## Key facts
- Earnings Releases
  GE HealthCare Technologies Inc. reported Fourth quarter and full year ended December 31, 2022 results: revenue Revenues of $4.9 billion, net income Net income was $554 million, EPS Earnings per share (EPS) from continuing operations were $1.21. Guidance reaffirmed.
  - Period: Fourth quarter and full year ended December 31, 2022
  - Revenue: Revenues of $4.9 billion
  - Net income: Net income was $554 million
  - EPS: Earnings per share (EPS) from continuing operations were $1.21
  - Guidance: reaffirmed
  - Result: reported results
  source text: access to care, and an aging population globally. We are well positioned to deliver on our 2023 commitments.” Fourth quarter 2022 total financial performance • Revenues of $4.9 billion increased 8% and 13% on an Organic basis* year-over-year, driven by growth in Imaging, Patient Care Solutions (PCS), and Ultrasound. Acquisitions favorably impacted total revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239323000007/0001932393-23-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.